FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> hepatitis C

Researchers find weakness in hep C virus

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!


Researchers from the University of New South Wales say they've discovered not one but two "Achilles heels" within the hepatitis C virus. The diseases' first weak point is in transmission, when it must move from person to person. The second comes three months after infection; the number of viral variants drops as the immune system responds, providing a window that may make it easier to target the virus. Article

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about hepatitis C